Targeting TFAM downregulation mediated mtDNA-NLRP3 pathway suppresses TAM infiltration and HCC progression-Reference-Cited by-同舟云学术

Targeting TFAM downregulation mediated mtDNA-NLRP3 pathway suppresses TAM infiltration and HCC progression

Published:2025-06-14 Issue: Volume: Page:
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Zhao Jing,Cui Mengmeng,Yao Xiaojuan,Jiang Zhixiong,Qi Lixia,Chen Jiaxing,Fan Chunhui,Bai Shuwen,Zhou Chengying,Wei Rui,Liu Hongliang,Yang Qi,Wan Lixin,Bao Dengke^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41388-025-03467-0.pdf

Reference43 articles.

1. Xu T, Yu S, Zhang J, Wu S. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers. J Hematol Oncol. 2021;14:181. https://doi.org/10.1186/s13045-021-01198-9.

2. Genard G, Lucas S, Michiels C. Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies. Front Immunol. 2017;8:828. https://doi.org/10.3389/fimmu.2017.00828.

3. Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829–845.e820. https://doi.org/10.1016/j.cell.2019.10.003.

4. Chew V, Lai L, Pan L, Lim CJ, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci USA. 2017;114:E5900–E5909. https://doi.org/10.1073/pnas.1706559114.

5. Zhou J, Wang W, Li Q. Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages. J Exp Clin Cancer Res. 2021;40:73. https://doi.org/10.1186/s13046-021-01873-2.